The impaired downstream signaling of IRS1/2 appears to be a key component of hepatic insulin resistance, yet studies on the correlation of IRS1 and 2 expression to MASLD have yielded contradictory results [20]. Here, IRS1 is linked to metabolic dysfunction-associated steatotic liver disease.